Curtis's Story
Watch Curtis's story and learn more about why diversity in clinical trials is important and consider why you should take part in a clinical trial
Clinical trial participants are key to developing safe treatments that work well to prevent, diagnose and treat kidney disease. The participants in clinical trials should represent the diverse group of people who have the health problem being studied and will use the treatment out in the world. However, Black, Hispanic, Native American and Asian American people are often underrepresented in clinical trials. This means that compared to the number of people from these communities who are living with kidney disease, few participate in clinical trials. Learn more about why diversity in clinical trials is important and consider why you should take part in a clinical trial.
Black, Hispanic, Native American and Asian American people have a greater chance of having kidney failure compared to white people. To make sure that treatments are safe and work for all people with kidney disease, it is important for clinical trials to include people from diverse backgrounds. Research has shown that people may have different reactions to treatments based on their race, ethnicity, gender, age and other factors. This is why it is important for clinical trial to include participants of different races, ethnicities, genders, and ages.
Currently, although people of color are more likely to have kidney failure, they are underrepresented in clinical trials. For example:
Before a treatment can be approved for use with patients, researchers must first test it for many years in a clinical trial. Clinical trials need different types of participants:
Through the four phases of a clinical trial, researchers answer the following questions by observing hundreds to thousands of volunteers:
After the new treatment is approved by the FDA, doctors can prescribe it to the public. This adds to the available treatment options for people living with kidney disease around the world. Clinical trials that test new treatments are just one type of clinical trial; there are many other types of clinical trials that need volunteers too.
Clinical trial participants play a key role in developing new ways to prevent, diagnose and treat kidney disease and learning more about rare diseases. For example:
Before deciding whether taking part in a clinical trial is right for you, it is important to understand what clinical trials involve, including:
If you are thinking about joining a clinical trial, talk with your doctor. Your doctor can discuss your treatment options to help you decide if a clinical trial is right for you. You doctor can also help you find a clinical trial that you may qualify for as a healthy or patient volunteer.
Before you decide to join a clinical trial, learn as much as you can about it. Every clinical trial has a treatment team who is there to help you understand how the clinical trial works and what being in the trial will mean for you. From talking to the treatment team, you can learn more about:
Be sure to talk to the treatment team about all your concerns. The more you know about the trial, the more confident you can feel about making a decision about whether to join. When preparing a list of questions, consider asking:
Get a list of more questions to ask the treatment team.
Share what you know about clinical trials with your family and friends, so they can consider if taking part in a clinical trial may be right for them. Researchers are looking for participants who have certain health problems and they are also looking for participants who do not have health problems (healthy volunteers). By spreading the word, you can help make sure that your community and people like you are represented. For example, share a link to AKF's clinical trials webpage , which includes a tool to find clinical trials you may qualify for.